Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Metformin use and survival outcomes in endometrial cancer: a systematic review and meta-analysis

Published:2017-08-22 Issue:42 Volume:8 Page:73079-73086
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Xie Weimin¹,Li Tianjia²,Yang Jing³,Shang Mengmeng⁴,Xiao Ying⁵,Li Qian⁶,Yang Jiaxin¹

Affiliation:

1. Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

2. Department of Vascular Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

3. Department of Obstetrics and Gynecology, Maternal and Child Health Care Hospital of Hunan Province, Changsha, China

4. Department of Scientific Research, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

5. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

6. Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis;Gynecologic Oncology;2024-03

2. Integrative Oncology’s 30-Year Anniversary: What Have We Achieved? A North American Naturopathic Oncology Perspective;Integrative Cancer Therapies;2023-01

3. Impact of Type 2 Diabetes Mellitus on Endometrial Cancer Survival: A Prospective Database Analysis;Frontiers in Oncology;2022-05-05

4. Factors influencing the anticancer effects of metformin on breast cancer outcomes: a systematic review and meta-analysis;Expert Review of Anticancer Therapy;2022-03-28

5. Clinical factors as prognostic variables among molecular subgroups of endometrial cancer;PLOS ONE;2020-11-24